Malaria has become a serious disease throughout recorded history and the pr
otozoan parasite of the family Plasmodidae is known to be the etiologic age
nt for this. The dangerously improved immunological status of various paras
ites (especially human malaria parasite P, falciparum) against conventional
drugs such as chloroquine necessitates the development of new agents havin
g optimum efficacy.